Adaptive Optics for Ophthalmic Technologies

NATerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Diabetic RetinopathyDiabetic Macular Edema
Interventions
DEVICE

WF-AO-OCT

WF-AO-OCT allows noninvasive, high-resolution imaging of the microvasculature of the retina and choroid, without intravenous dye administration. This unit is being conducted under an abbreviated IDE.

Trial Locations (1)

27710

Duke Eye Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER

NCT02826655 - Adaptive Optics for Ophthalmic Technologies | Biotech Hunter | Biotech Hunter